Arming the Body to Fight Ovarian Cancer
Guest Post by Roswell Park Cancer Institute Department of Public Affairs
Category: Research
Guest Post by Roswell Park Cancer Institute Department of Public Affairs
An emerging hallmark of cancer cells is their ability to hide from the body’s immune system. The human immune...
The number of anticancer immunotherapeutics approved by the U.S. Food and Drug Administration (FDA) is rising rapidly. In fact,...
On the heels of the U.S. Food and Drug Administration’s approval of a combination of immune checkpoint inhibitors for...
Government task force drafts recommendations for low-dose aspirin for the prevention of cardiovascular disease and colorectal cancer; a study...
The inaugural International Cancer Immunotherapy Conference, hosted jointly by the Cancer Research Institute (CRI), the Association for Cancer Immunotherapy...
Two studies published today in the AACR's journal Cancer Research describe developing CAR T cells to make them safe...
Guest Post by Barbara A. Conley, MD National Cancer Institute (NCI)
Bladder cancer is the fifth most common cancer in the United States, predominantly affecting men in the later decades...
Last week, the U.S. Food and Drug Administration (FDA) approved a new anticancer therapeutic called sonidegib (Odomzo) for patients...